Bank of New York Mellon’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-655,472
| Closed | -$2.62M | – | 4238 |
|
|
2019
Q4 | $2.62M | Buy |
655,472
+5,158
| +0.8% | +$24.2K | ﹤0.01% | 2653 |
|
|
2019
Q3 | $3.19M | Sell |
650,314
-27,031
| -4% | -$151K | ﹤0.01% | 2508 |
|
|
2019
Q2 | $4.13M | Buy |
677,345
+29,327
| +5% | +$156K | ﹤0.01% | 2427 |
|
|
2019
Q1 | $3.77M | Sell |
648,018
-1,034,572
| -61% | -$10.7M | ﹤0.01% | 2469 |
|
|
2018
Q4 | $22.6M | Buy |
1,682,590
+830,436
| +97% | +$14M | 0.01% | 1393 |
|
|
2018
Q3 | $16.5M | Sell |
852,154
-22,792
| -3% | -$485K | ﹤0.01% | 1737 |
|
|
2018
Q2 | $22.4M | Sell |
874,946
-39,235
| -4% | -$915K | 0.01% | 1534 |
|
|
2018
Q1 | $18.4M | Buy |
914,181
+282,817
| +45% | +$6.6M | 0.01% | 1614 |
|
|
2017
Q4 | $12.7M | Buy |
631,364
+27,837
| +5% | +$547K | ﹤0.01% | 1871 |
|
|
2017
Q3 | $12.5M | Buy |
603,527
+19,930
| +3% | +$337K | ﹤0.01% | 1876 |
|
|
2017
Q2 | $8.64M | Buy |
583,597
+10,806
| +2% | +$180K | ﹤0.01% | 2058 |
|
|
2017
Q1 | $9.14M | Buy |
572,791
+23,074
| +4% | +$333K | ﹤0.01% | 2021 |
|
|
2016
Q4 | $6.93M | Sell |
549,717
-2,569
| -0.5% | -$47.8K | ﹤0.01% | 2154 |
|
|
2016
Q3 | $15.5M | Buy |
552,286
+63,110
| +13% | +$2.12M | ﹤0.01% | 1601 |
|
|
2016
Q2 | $17.1M | Sell |
489,176
-4,291
| -0.9% | -$135K | 0.01% | 1502 |
|
|
2016
Q1 | $13.5M | Buy |
493,467
+248,925
| +102% | +$7.33M | ﹤0.01% | 1656 |
|
|
2015
Q4 | $8.37M | Sell |
244,542
-43,557
| -15% | -$1.36M | ﹤0.01% | 1940 |
|
|
2015
Q3 | $8.28M | Sell |
288,099
-13,203
| -4% | -$565K | ﹤0.01% | 1963 |
|
|
2015
Q2 | $13.5M | Buy |
301,302
+209,913
| +230% | +$7.9M | ﹤0.01% | 1775 |
|
|
2015
Q1 | $3.16M | Buy |
91,389
+36,678
| +67% | +$998K | ﹤0.01% | 2574 |
|
|
2014
Q4 | $1.5M | Buy |
+54,711
| New | +$1.33M | ﹤0.01% | 3044 |
|
Other funds holding DPLO
Bank of New York Mellon's DPLO Position: Q1 2020 in Review
Bank of New York Mellon sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 655,472 shares — an estimated $2.62M sold.
Bank of New York Mellon first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $22.6M in Q4 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Bank of New York Mellon reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Bank of New York Mellon sold 655,472 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.62M.
- Bank of New York Mellon first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Bank of New York Mellon's DIPLOMAT PHARMACY, INC. position peaked at $22.6M in Q4 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Bank of New York Mellon's 13F filing for Q1 2020, filed 6 May 2020.